CRBP Q1 2026 Earnings Narrower Loss Beats Estimates but No Revenue and Sharp Share Decline Raise Concerns MIAX Q1 2026 Earnings EPS Surpasses Estimates by 98 Amid Stable Operations Cytek Biosciences Q1 2026 Earnings Deep EPS Miss Fails to Dampen Investor Sentiment Nanobiotix SA NBTX Q4 2025 Earnings Wide EPS Miss Stock Edges Higher on Clinical Progress Stepan Company SCL Q1 2026 Earnings EPS Slightly Exceeds Estimates Stock Rises DTB Q1 2026 Earnings EPS Falls Short of Expectations Amid Flat Market Response